Application and management of continuous glucose monitoring in diabetic kidney disease

doi:10.4239/wjd.v15.i4.591

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (963)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-1) series.

Item

Count

PDF

WORD

HTML

641

Tables (1-1)

Sum=751

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

109

Sum=137

Apr 15, 2024 (publication date) through Jul 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Diabetes. Apr 15, 2024; 15(4): 591-597
Published online Apr 15, 2024. doi: 10.4239/wjd.v15.i4.591

Application and management of continuous glucose monitoring in diabetic kidney disease

Xin-Miao Zhang, Quan-Quan Shen

Xin-Miao Zhang, Geriatric Medicine Center, Department of Endocrinology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou 310014, Zhejiang Province, China

Quan-Quan Shen, Urology and Nephrology Center, Department of Nephrology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou 310014, Zhejiang Province, China

Author contributions: Zhang XM drafted the manuscript; Shen QQ designed the research and revised the manuscript; all authors have read and approved the final manuscript.

Supported by Natural Science Foundation of Zhejiang Province, No. LY23H050005; and Zhejiang Medical Technology Project, No. 2022RC009.

Conflict-of-interest statement: We have no financial relationships to disclose.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Quan-Quan Shen, MD, Associate Professor, Doctor, Urology and Nephrology Center, Department of Nephrology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), No. 158 Shangtang Road, Hangzhou 310014, Zhejiang Province, China. spring198457@sina.com

Received: December 10, 2023
Peer-review started: December 10, 2023
First decision: January 25, 2024
Revised: February 1, 2024
Accepted: March 1, 2024
Article in press: March 1, 2024
Published online: April 15, 2024
Processing time: 123 Days and 14.3 Hours

Core Tip

Core Tip: Continuous glucose monitoring (CGM) shows the strength of providing a glycemic profile in diabetic kidney disease (DKD). This article summarizes the use of CGM in early and advanced stages of DKD, including hemodialysis, peritoneal dialysis, and kidney transplantation. CGM may be considered an alternative or complement to measurement of hemoglobin A1c in some contexts.